WO2023017393 - PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF
National phase entry:
Publication Number
WO/2023/017393
Publication Date
16.02.2023
International Application No.
PCT/IB2022/057356
International Filing Date
08.08.2022
Title **
[English]
PROCESS FOR THE PREPARATION OF OLAPARIB, AND CRYSTALLINE FORM THEREOF
[French]
PROCÉDÉ DE PRÉPARATION D'OLAPARIB ET SA FORME CRISTALLINE
Applicants **
GLENMARK LIFE SCIENCES LIMITED
Glenmark House, HDO- Corporate Building, Wing-A, B. D. Sawant Marg, Chakala, Andheri (East), Mumbai 400099, Maharashtra, IN
Inventors
PALLE, Venkata Raghavendra Charyulu
Bungalow 24, Gera Green Ville, Survey no. 64, Grant Road, Kharadi, Pune,
Maharashtra, 411014, IN
PATEL, Pratik R.
7, Anand Vihar, Gotri Vasna Road, Gotri, Vadodara, Gujarat, 390021, IN
ALI, Nasir
Flat no.1604 Maxima-E, Casa bella Gold, Kalyan Shil Road, Palava, Dombivali E, Thane, Maharashtra, 421204, IN
SHELKE, Shivaji Haribhau
B-104, Beverlee, Casa Rio, Kalyan Shil Road, Palava, Dombivali E, Thane
Maharashtra, 421204, IN
LAD, Sachin Mahadeo
A2/206, Raj Residency, GB Road, Kasarvadavali, Thane west
Maharashtra, 400607, IN
PATLE, Girish Tilakchand
Flat No.1204, Sidhivinayak orchid, Plot no.14, Sector 20, Sion-Pune Highway,
Kalamboli-Panvel. Maharashtra, 410218, IN
SHANMUGHASAMY, Raj Mahendra
Plot.No.35, Silver castle, Chinna Elasagiri, Hosur, Tamilnadu, 635126, IN
YADAV, Premkumar Ramraj
105, Shree Ashapura Residency, Plot No A/5/1, Khanda Colony, Sector-7, New Panvel, Maharashtra, 410206, IN
Priority Data
202121035948
09.08.2021
IN
202221012208
07.03.2022
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1523 | |
| EPO | Filing, Examination | 9801 | |
| Japan | Filing | 587 | |
| South Korea | Filing | 606 | |
| USA | Filing, Examination | 8510 |
Total: 21027 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to a process for the preparation of olaparib. The present invention also relates to a novel crystalline form of olaparib, and a process for its preparation. Further, the present invention also relates to a pharmaceutical composition containing a therapeutically effective amount of the novel crystalline form of olaparib. Also, the present invention relates to improved processes for the preparation of crystalline form H and crystalline form A of olaparib.[French]
La présente invention concerne un procédé de préparation d'olaparib. La présente invention concerne également une nouvelle forme cristalline d'olaparib, et un procédé pour sa préparation. En outre, la présente invention concerne également une composition pharmaceutique contenant une quantité thérapeutiquement efficace de la nouvelle forme cristalline d'olaparib. La présente invention concerne également des procédés améliorés pour la préparation de la forme cristalline H et de la forme cristalline A d'olaparib.